Microbes Are Associated with Host Innate Immune Response in Idiopathic Pulmonary Fibrosis
Yong Huang(Institute of Infection and Immunity), Imre Noth(University of Virginia), Kevin R. Flaherty(University of Michigan), Rekha Vij(University of Chicago), Bethany B. Moore(University of Michigan), MeiLan K. Han(University of Michigan), Joe G. N. Garcia(Scripps Research Institute), Eric S. White(Boehringer Ingelheim (United Kingdom)), Tong Zhou(Jiangsu Academy of Agricultural Sciences), John R. Erb‐Downward(University of Michigan), Shwu‐Fan Ma(University of Chicago), Yves A. Lussier(Université du Québec à Trois-Rivières), Cory M. Hogaboam(Cedars-Sinai Medical Center), Gary B. Huffnagle(University of Michigan), Naftali Kaminski(Yale University), Jiànróng Lǐ(University of Arizona), Milena S. Espíndola(Cedars-Sinai Medical Center), Fernando J. Martínez(University of Massachusetts Chan Medical School), Justin M. Oldham(Michigan Medicine)
Cited by 140
Related Papers
Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper
|European Respiratory Journal|2004|4.4k
An Official American Thoracic Society/European Respiratory Society Statement: Update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias
|American Journal of Respiratory and Critical Care Medicine|2013|4.3k
Diagnosis of Idiopathic Pulmonary Fibrosis. An Official ATS/ERS/JRS/ALAT Clinical Practice Guideline
|American Journal of Respiratory and Critical Care Medicine|2018|4.1k
Clinical Characteristics of Covid-19 in New York City
|New England Journal of Medicine|2020|2.4k
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
|New England Journal of Medicine|2019|2.3k